Cepheid: Revolutionizing Molecular Diagnostics
Experience Innovative Diagnostic Testing with Cepheid GeneXpert® Systems and Tests
A Better Way
Cepheid is a top choice in diagnostic partnerships for delivering reliable results and groundbreaking innovation. Our solutions can drive transformative advances in medicine, increasing impact and accessibility to testing when and where it's needed. When it comes to patients' lives, the value of trust is built on accurate results.
Transformation starts with One Cartridge. One Platform. Total Solution.
Cepheid's extensive PCR testing menu covers a wide range of diseases, including respiratory infections, blood virology, women's and sexual health, tuberculosis, emerging infectious diseases, healthcare-associated infectious diseases, oncology, and human genetics.
MORE solutions
With Cepheid's GeneXpert® system and Xpert® tests, you have a powerful diagnostic solution that provides accurate and actionable results quickly and efficiently. This can streamline the process and revolutionize diagnostics to enhance patient outcomes. Our commitment is to deliver a better way by enabling access to PCR testing everywhere.
Does your current diagnostic solution deliver the confidence you need, and the results patients deserve? Compare your test today with the impact Cepheid delivers.
MORE impact
Here’s how Cepheid measures up with a PCRplus advantage.
- Accuracy – deliver confident results that aid in appropriate patient treatment with a test design that features real-time PCR in a more flexible, scalable, and user-friendly format.
- Speed and Efficiency – deliver results on the same day or during the same visit, improving linkage to care and patient management.
- Simplicity – easy-to-use workflow minimizes time spent training staff and can potentially improve employee satisfaction and overall management.
Trust isn’t just a feeling, it’s a belief. Cepheid delivers a better way. Connect with your Cepheid partner today.
Cepheid's GeneXpert System
Experience the GeneXpert Advantage
Easy-to-use random-access system enables on-demand testing, offering flexibility and efficiency over traditional large batch processing. It is a market leader^ in sample-to-answer PCR diagnostic testing with the largest global installed base^ and operates in over 180 countries.
Scalable: Run one to 80 tests at a time
Flexible: Run any combination of tests simultaneously
Cepheid's Xpert Tests
Empowering Precision Medicine
Lab in a Cartridge™ technology enables sample-to-answer rapid testing with a self-contained, single-use test cartridge that automates nucleic acid extraction, PCR amplification, and target sequence detection.
Request Information
Complete the form below to be connected with an expert of the team.
GeneXpert Family of Systems
Standardized yet scalable systems across the healthcare continuum.
- GeneXpert System with Touchscreen - Cepheid's GeneXpert system with touchscreen combines speed, accuracy, simplicity, and an intuitive user interface to deliver PCR results anywhere testing is needed.
- GeneXpert Infinity - Enable a comprehensive menu of tests to be run on a single system by a single operator in a moderately complex, real-time environment.
- GeneXpert Xpress - CLIA waived molecular testing for any healthcare setting — from community hospitals to physician offices, point of care locations, and specialty clinics.
Respiratory Tests
- Xpert Xpress Strep A: Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes1
- Xpert Xpress CoV-2/Flu/RSV plus*: Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses#
- Xpert Xpress CoV-2 plus*: A rapid, near-patient test for the SARS-CoV-2 respiratory virus detection, including emerging variants, to provide timely, effective triage#
- Xpert Xpress Flu#: Accurate and reliable detection of Flu A and Flu B, in as soon as 20 minutes1
Hospital Associated Infections &
Other Infectious Diseases
- Xpert Carba-R: Detects KPC, NDM, VIM, OXA-48, and IMP in 50 minutes
- Xpert C. difficile: Detection of Clostridium difficile in as soon as 40 minutes1
- Xpert C. difficile/Epi: 45-minute detection & differentiation of Clostridium difficile and the Epidemic 027 strain
- Xpert MRSA/SA Blood Culture: Accurate detection of Staphylococcus aureus (SA) and MRSA in positive blood culture specimens in about an hour
- Xpert MRSA/SA SSTI: Detection of MRSA & SA skin and soft tissue infections in about one hour from nasal swabs
- Xpert MRSA NxG: Accurate, fast, on-demand PCR test that detects Methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal swabs
- Xpert Norovirus: Rapid identification and differentiation of Norovirus GI and GII in less than one hour1
- Xpert SA Nasal Complete: detection of S. aureus and MRSA in about an hour
- Xpert vanA: Rapid and accurate test to assist with VRE surveillance
Women's & Sexual Health
- Xpert Xpress MVP: On-demand PCR test to aid in the diagnosis of bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis in symptomatic women from a single swab within an hour
- Xpert HCV: Point-of-care hepatitis C RNA test that enables same-day care
- Xpert Xpress GBS: Direct intrapartum group B strep results within an hour for labor/delivery
- Xpert GBS LB XC: On-demand antepartum group B strep PCR screening test from lim broth
- Xpert CT/NG: 90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
- Xpert TV: Fast and accurate diagnosis of trichomoniasis for both women and men in about 42 minutes1
TB & Emerging Infectious Diseases
- Xpert Ebola*: Detection of Ebola Zaire virus in around 90 minutes
- Xpert Mpox*: On-demand Mpox testing provides accurate point-of-care results in approximately 36 minutes
- Xpert MTB/RIF: Accurate detection of MTB and Rifampin resistance mutations
Oncology & Human Genetics
- Xpert FII & FV: 30-minute test for genetic risk of thrombosis
- Xpert BCR-ABL Ultra: Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
- Xpert® BCR-ABL Ultra p190 (RUO): Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript. For Research Use Only (RUO).
- Xpert NPM1 Mutation (RUO): Quantitative assay of the NPM1 mRNA transcripts (Type A, B, and D) and the ABL1 endogenous control mRNA transcript in EDTA peripheral blood samples. For Research Use Only (RUO)
- Xpert PML RARA (RUO): Quantitative assay for the PML-RARA fusion transcript in EDTA peripheral blood samples. For Research Use Only (RUO).
Lab in a Cartridge™
Bringing the full power of molecular testing closer to the patient. Discover how it's Simpler with Cepheid.
The Real Cost of Changing to PCR Testing
Understanding the total impact on workflow and improved efficiencies with PCR diagnostic testing.
PCR Testing is Available for Testing Many Diseases
PCR testing has been recognized as a gold standard for detecting COVID-19; it can also be used to test for many other diseases.
What is PCR? Understand the Magic
Find out why PCR has become the standard for quality diagnostic testing.
Dr. Tenover breaks it down for us.
- Fully automated sample extraction, PCR amplification, and detection
- Simple workflow with minimal hands-on time and walk away capabilities for unparalleled efficiency
- Fast and accurate PCR results, with most test results in less than one hour
- Laboratory information system (LIS) and electronic medical record (EMR) interface capabilities
- Compact and scalable design options to grow with your testing needs
- Closed cartridge technology reduces the risk of contamination and enables random-access, mix-and-match testing capabilities for optimal flexibility.
Ready to learn more about Cepheid's diagnostic solutions?
Connect with our team of experts for personalized guidance and support. Together, let's advance healthcare and enhance patient outcomes.
US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
* These tests have not been FDA cleared or approved. These tests have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. Xpert Mpox has been authorized only for the detection of nucleic acid from monkeypox virus or other non-variola orthopoxviruses, not for any other viruses or pathogens. Xpert Ebloa has been authorized only for the detection of Ebola Zaire virus (detected in the West Africa outbreak in 2014). The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19, monkeypox virus, including non-variola Orthopoxvirus, and/or Ebola virus under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
^ Based on internal install reports.
# In vitro diagnostic device for use in Moderate Complexity or CLIA waived settings.
1. With early assay termination (EAT) for positive results. Full test runtimes are as follows: Xpert Xpress Flu is 30 minutes, Xpert Xpress CoV-2 plus is approximately 30 minutes, Xpert Xpress Strep A is 24 minutes, Xpert TV is 70 minutes, Xpert C. difficile is 43 minutes. With early assay termination for positives when running SARS-CoV-2 only on Xpert Xpress CoV-2/Flu/RSV plus full run time is 36 min. Xpert Norovirus is 88 minutes.
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.
For more information, visit www.cepheid.com
904 Caribbean Drive, Sunnyvale, CA 94089
©2024 Cepheid. All Rights Reserved.